This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Johanna M. Seddon; Walter Willett, MD
Massachusetts Eye and Ear Infirmary Boston

Robert D. Sperduto, MD
National Eye Institute Bethesda, Md for the Eye Disease Case-Control Study Group

JAMA. 1995;273(23):1835.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Randomized trials of beta carotene or any one vitamin will not be able to answer all questions about the role of all antioxidants in the development or progression of age-related eye disease. The Editorial¹ accompanying our article reminds us that the success of the clinical trials in finding an association "depends on giving the appropriate nutrient, in the appropriate dose, for an appropriate period of time, to an appropriate population. Failing to meet any one of these requirements will reduce or eliminate the probability of finding an effect even if one exists." As we discussed in our article, observational studies and clinical trials both can contribute to our understanding of the relationship between antioxidants as well as other nutrients and risk of chronic eye disease. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?